SCHEMBL1748065

SCHEMBL1748065

C[C@@]1(C(=O)O)CCC[C@H]1C(=O)c1ccc(-c2ccc(Nc3nc4ccccc4[nH]3)c(F)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 3/20 0.41
NPC1 O15118 8/20 0.39
RAB9A P51151 8/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
POLB P06746 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
AKR1C3 P42330 1/20 0.38
IRAK4 Q9NWZ3 1/20 0.38
KDM4E B2RXH2 1/20 0.37
TP53 P04637 1/20 0.37
PKM P14618 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CYP1A2 P05177 1/20 0.37
MEN1 O00255 1/20 0.37
CASP3 P42574 1/20 0.37
KMT2A Q03164 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
HTR2B P41595 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL2310230 0.83 NPC1 (0.52) DGAT1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL1748153 0.81 DGAT1 (0.59) DGAT1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL5984327 0.81 DGAT1 (0.59) DGAT1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL1748064 0.79 DGAT1 (0.48) DGAT1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL2309580 0.77 DGAT1 (0.41) DGAT1KDM4EHSD17B10
SCHEMBL1748238 0.76 DGAT1 (0.42) DGAT1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL1748122 0.75 DGAT1 (0.50) DGAT1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL1748172 0.74 DGAT1 (0.36) DGAT1KDM4EHSD17B10HDAC6
SCHEMBL1747988 0.73 DGAT1 (0.72) DGAT1SMN1; SMN2KDM4EMEN1KMT2A
Bicarbonate SCHEMBL2307118 0.72 DGAT1 (0.46) DGAT1NPC1RAB9ASMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8013166-B2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity BAYER HEALTHCARE LLC (US) 2011-09-06 US disclosed
EP-1633722-B1 PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY BAYER HEALTHCARE LLC (US) 2011-08-03 EP disclosed